Barbosa, Bárbara Lima Fonseca; Freitas, Tulio Resende; Almeida, Michell de Oliveira 
; Araújo, Sérgio Schusterschitz da Silva; Andrade, Ana Clara; Dornelas, Geovana Gomes; Fiorotto, Julyana Gayva; Maltarollo, Vinicius Gonçalves; Sabino, Adriano de Paula
Fonte: Future Pharmacology. Unidade: IQSC
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARBOSA, Bárbara Lima Fonseca et al. Virtual Screening of Adenylate Kinase 3 Inhibitors Employing Pharmacophoric Model, Molecular Docking, and Molecular Dynamics Simulations as Potential Therapeutic Target in Chronic Lymphocytic Leukemia. Future Pharmacology, v. 1, p. 60–79, 2021Tradução . . Disponível em: https://doi.org/10.3390/futurepharmacol1010006. Acesso em: 18 set. 2024.APA
Barbosa, B. L. F., Freitas, T. R., Almeida, M. de O., Araújo, S. S. da S., Andrade, A. C., Dornelas, G. G., et al. (2021). Virtual Screening of Adenylate Kinase 3 Inhibitors Employing Pharmacophoric Model, Molecular Docking, and Molecular Dynamics Simulations as Potential Therapeutic Target in Chronic Lymphocytic Leukemia. Future Pharmacology, 1, 60–79. doi:10.3390/futurepharmacol1010006NLM
Barbosa BLF, Freitas TR, Almeida M de O, Araújo SS da S, Andrade AC, Dornelas GG, Fiorotto JG, Maltarollo VG, Sabino A de P. Virtual Screening of Adenylate Kinase 3 Inhibitors Employing Pharmacophoric Model, Molecular Docking, and Molecular Dynamics Simulations as Potential Therapeutic Target in Chronic Lymphocytic Leukemia [Internet]. Future Pharmacology. 2021 ;1 60–79.[citado 2024 set. 18 ] Available from: https://doi.org/10.3390/futurepharmacol1010006Vancouver
Barbosa BLF, Freitas TR, Almeida M de O, Araújo SS da S, Andrade AC, Dornelas GG, Fiorotto JG, Maltarollo VG, Sabino A de P. Virtual Screening of Adenylate Kinase 3 Inhibitors Employing Pharmacophoric Model, Molecular Docking, and Molecular Dynamics Simulations as Potential Therapeutic Target in Chronic Lymphocytic Leukemia [Internet]. Future Pharmacology. 2021 ;1 60–79.[citado 2024 set. 18 ] Available from: https://doi.org/10.3390/futurepharmacol1010006
